My Symptoms Symptoms of Disorders When to See a Doctor Tests I Might Need

Statistics Barrett's Esophagus Celiac Disease Colon Cancer Constipation Crohn's Disease Diarrhea Diverticular Disease Dyspepsia Esophageal Cancer GERD Inflammatory Bowel Disease (IBD) Irritable Bowel Syndrome (IBS) Lactose Intolerance Pancreatitis Peptic Ulcer Ulcerative Colitis

Personal Stories

Barrett's Esophagus Celiac Disease Colon Cancer Crohn's Disease Esophageal Cancer GERD Inflammatory Bowel Disease (IBD) Irritable Bowel Syndrome (IBS) Ulcerative Colitis

Tell Us Your Story

Ask Our Doctor Brochures Fact Sheets FAQ Glossary Features and Publications Newsletter Videos WebSeminars

Your Digestive System Protect Your Digestive Health Food and Digestive Health Related Links

News

Research

Research Articles CDHF Researchers Opportunities - Research Funding

Who We Are Priority Initiatives Leadership Ambassadors Partners Events Donate Financial Statements Contact Us Privacy Policy

Home > About Us > Partners > Shire

Shire

Shire Canada Inc. is a wholly owned subsidiary of Shire plc, a global specialty biopharmaceutical company that works closely with specialist physicians to develop and market medicines that improve the quality of life for patients, their families and caregivers. Shire focuses on attention deficit hyperactivity disorder (ADHD), human genetic therapies and gastrointestinal diseases. Shire Canada's operations are headquartered in Montréal, Québec.

For further information on Shire, please visit the Company's website: www.shire.com.